Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)

SHA:603858 Revenue

Shandong Buchang Pharmaceuticals had revenue of 2.58B CNY in the quarter ending March 31, 2026, a decrease of -7.39%. This brings the company's revenue in the last twelve months to 11.67B, up 4.65% year-over-year. In the year 2025, Shandong Buchang Pharmaceuticals had annual revenue of 11.88B with 7.90% growth.

• Revenue (ttm): 11.67B
• Revenue Growth: +4.65%
• P/S Ratio: 1.37
• Revenue / Employee: 1.61M
• Employees: 7,237
• Market Cap: 16.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	11.88B	869.22M	7.90%
Dec 31, 2024	11.01B	-2.24B	-16.91%
Dec 31, 2023	13.25B	-1.71B	-11.41%
Dec 31, 2022	14.95B	-811.43M	-5.15%
Dec 31, 2021	15.76B	-244.03M	-1.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error